AU2001259051A1 - Piperidyindoles as serotonin receptor ligands - Google Patents
Piperidyindoles as serotonin receptor ligandsInfo
- Publication number
- AU2001259051A1 AU2001259051A1 AU2001259051A AU5905101A AU2001259051A1 AU 2001259051 A1 AU2001259051 A1 AU 2001259051A1 AU 2001259051 A AU2001259051 A AU 2001259051A AU 5905101 A AU5905101 A AU 5905101A AU 2001259051 A1 AU2001259051 A1 AU 2001259051A1
- Authority
- AU
- Australia
- Prior art keywords
- piperidyindoles
- receptor ligands
- serotonin receptor
- serotonin
- ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0012082A GB2362381A (en) | 2000-05-18 | 2000-05-18 | Pharmaceutically active indolyl-piperidines |
GB0012082 | 2000-05-18 | ||
PCT/US2001/011744 WO2001087881A1 (fr) | 2000-05-18 | 2001-05-04 | Piperidyindoles comme ligands du recepteur de la serotonine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001259051A1 true AU2001259051A1 (en) | 2001-11-26 |
Family
ID=9891893
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001259051A Abandoned AU2001259051A1 (en) | 2000-05-18 | 2001-05-04 | Piperidyindoles as serotonin receptor ligands |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1286992A1 (fr) |
JP (1) | JP2003533523A (fr) |
AU (1) | AU2001259051A1 (fr) |
CA (1) | CA2410091A1 (fr) |
GB (1) | GB2362381A (fr) |
WO (1) | WO2001087881A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR028685A1 (es) * | 2000-06-14 | 2003-05-21 | Lundbeck & Co As H | Derivados de indol |
DK1294710T3 (da) * | 2000-06-14 | 2005-10-03 | Lundbeck & Co As H | Indolderivater, der er egnede til behandlingen af CNS-lidelser |
TWI391387B (zh) * | 2004-05-12 | 2013-04-01 | Eisai R&D Man Co Ltd | 具有哌啶環之吲哚衍生物 |
AU2006244914A1 (en) * | 2005-05-11 | 2006-11-16 | Eisai R & D Management Co., Ltd. | Crystal of indole derivative having piperidine ring and process for production thereof |
CN101171249B (zh) * | 2005-05-11 | 2010-11-10 | 卫材R&D管理有限公司 | 制备具有哌啶环的吲哚衍生物的方法 |
JP4932717B2 (ja) | 2005-05-11 | 2012-05-16 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ピペリジン環を有するインドール誘導体の製造方法 |
CL2007003591A1 (es) * | 2006-12-12 | 2008-02-29 | Wyeth Corp | Compuestos derivados de sulfonamida ciclicos, inhibidores de retoma de monoamina; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de disfuncion sexual, trastorno gastrointestinal, trastorno genitourinari |
US7718652B2 (en) | 2006-12-12 | 2010-05-18 | Wyeth Llc | Substituted benzothiadiazinedioxide derivatives and methods of their use |
CN101250154B (zh) * | 2008-03-13 | 2011-05-04 | 台州市知青化工有限公司 | 一种工业化生产6-氟吲哚的方法 |
CN109476606B (zh) | 2016-07-04 | 2023-01-20 | 拜耳作物科学股份公司 | 苯并磺内酰胺和类似物及其作为杀真菌剂的用途 |
CN112457235B (zh) * | 2020-12-02 | 2023-04-25 | 烟台凯博医药科技有限公司 | 一种7-甲基吲哚的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
FR2621588B1 (fr) * | 1987-10-08 | 1991-05-24 | Roussel Uclaf | Nouveaux derives de la 1,1-dioxo 1,2-benzoisothiazol 3-one, leur procede de preparation et leur application comme medicaments |
IL90858A (en) * | 1988-07-07 | 1994-08-26 | Rhone Poulenc Sante | History (Aza) Naftalensultam, their preparation and preparations containing them |
ES2139595T3 (es) * | 1991-04-23 | 2000-02-16 | Toray Industries | Derivados triazolicos triciclicos, fabricacion de los mismos y su utilizacion. |
FR2675801A1 (fr) * | 1991-04-24 | 1992-10-30 | Rhone Poulenc Rorer Sa | Piperidines, leur preparation et les medicaments les contenant. |
DE19500689A1 (de) * | 1995-01-12 | 1996-07-18 | Merck Patent Gmbh | Indolpiperidin-Derivate |
WO1999010346A1 (fr) * | 1997-08-22 | 1999-03-04 | Eli Lilly And Company Limited | Derives de benzothiadiazinyl-indole et leur utilisation comme ligands recepteurs de la serotonine |
GB9810886D0 (en) * | 1998-05-13 | 1998-07-22 | Lilly Industries Ltd | Pharmaceutical compounds |
GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
GB9903784D0 (en) * | 1999-02-18 | 1999-04-14 | Lilly Co Eli | Pharmaceutical compounds |
KR20010085555A (ko) * | 1999-06-24 | 2001-09-07 | 히라이 가쯔히꼬 | 아드레날린 알파1비 수용체 길항약 |
-
2000
- 2000-05-18 GB GB0012082A patent/GB2362381A/en not_active Withdrawn
-
2001
- 2001-05-04 JP JP2001584275A patent/JP2003533523A/ja not_active Withdrawn
- 2001-05-04 WO PCT/US2001/011744 patent/WO2001087881A1/fr not_active Application Discontinuation
- 2001-05-04 CA CA002410091A patent/CA2410091A1/fr not_active Abandoned
- 2001-05-04 EP EP01932534A patent/EP1286992A1/fr not_active Withdrawn
- 2001-05-04 AU AU2001259051A patent/AU2001259051A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB0012082D0 (en) | 2000-07-12 |
JP2003533523A (ja) | 2003-11-11 |
GB2362381A (en) | 2001-11-21 |
WO2001087881A1 (fr) | 2001-11-22 |
CA2410091A1 (fr) | 2001-11-22 |
EP1286992A1 (fr) | 2003-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4802500A (en) | 2-aminoquinolinecarboxamides: neurokinin receptor ligands | |
HK1045512A1 (en) | Tetracyclic azepinoindole compounds as 5-ht receptor ligands. | |
AU2708901A (en) | Compounds exhibiting thrombopoietin receptor agonism | |
AU2002218266A1 (en) | Novel indanylidene compounds | |
AU1738900A (en) | Serotonin ligands as pro-erectile compounds | |
AU2001242744A1 (en) | Diphenylalkylamine derivatives useful as opioid delta receptor ligands | |
AU2001292518A1 (en) | Novel compounds | |
AUPQ910500A0 (en) | Support means | |
AU2001263485A1 (en) | Bracket | |
AU2001239765A1 (en) | Novel compounds | |
AU5319700A (en) | Nicotine receptor ligands | |
AU2001246998A1 (en) | Novel compounds | |
AU2001259051A1 (en) | Piperidyindoles as serotonin receptor ligands | |
AU6032100A (en) | New compounds | |
AU2001253362A1 (en) | Novel compounds | |
AU2001256964A1 (en) | Novel compounds | |
AU2001295455A1 (en) | Indoline derivatives as 5ht2c antagonists | |
AU2002212445A1 (en) | Signalling means | |
AU2001270822A1 (en) | Imidazolophthalazine derivatives as ligands for gabaa receptors | |
AU2001237546A1 (en) | Methods for characterizing polymorphisms | |
AU2001249250A1 (en) | Selective ligands for the delta opioid receptor | |
AU2001230689A1 (en) | Novel compounds | |
AU2001234042A1 (en) | Support network | |
AU2002216060A1 (en) | Novel compounds | |
AUPQ563400A0 (en) | Novel receptor |